Nodal Therapeutics, Inc. — Form D/A
Nodal Therapeutics, Inc. of SILVER SPRING, MD, a company, filed a Form D amendment with the SEC on 2024-10-29. The offering totals $250K, of which $250K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-10-29
- Form: D/A
- Accession: 0002024197-24-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $250K
- Amount sold: $250K
- Investors: 1
- Date of first sale: 2024-05-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-515359
Issuer
- Name: Nodal Therapeutics, Inc.
- CIK: 0002024197
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 1804 EDGEWATER PARKWAY, SILVER SPRING, MD, 20903
- Phone: 608-215-5779
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Christopher Jewell | Director | Silver Spring, MD |
| Jonathan S Bromberg | Executive Officer | Silver Spring, MD |
| Christopher Jewell | Executive Officer | Silver Spring, MD |
Other filings by this issuer (1)
More